Diana V. Vakhrusheva - Infectious Diseases

Author Information

Diana V. Vakhrusheva is affiliated with the Ural Research Institute for Phthisiopulmonology, which is part of the National Medical Research Center of Tuberculosis and Infectious Diseases under the Ministry of Health of the Russian Federation, based in Yekaterinburg, Russia. Her work primarily focuses on tuberculosis and infectious diseases, contributing significantly to the understanding and treatment of these conditions.

Research Contributions

Diana V. Vakhrusheva has made considerable contributions to the field of infectious diseases, with a particular emphasis on tuberculosis. Her research includes the molecular characterization of drug-resistant Mycobacterium tuberculosis, the development of methods for drug susceptibility testing, and the exploration of biobanking as a crucial resource for research in phthisiology. She has also investigated antimycobacterial signaling pathways, phenotypic resistance, and the prevalence of epidemic variants of the Mycobacterium tuberculosis Beijing genotype in Russian regions.

Aliases

Diana V. Vakhrusheva is also known under several aliases, including Diana V Vakhrusheva, D.v. Vakhrusheva, D. V. Vakhrusheva, and Diana Vakhrusheva.

Publication and Citation Metrics

Metric	Value
Total Citation Count	85
H-Index	6
Total Paper Count	46

Publications:

Molecular Characteristics of Mycobacterium Tuberculosis Drug-Resistant Isolates from HIV- and HIV+ Tuberculosis Patients in Russia

DOI: 10.21203/rs.3.rs-1159825/v1

Year: 2022

Comparison of Different Methods for Drug Susceptibility Testing of Mycobacterium tuberculosis to Rifampicin

DOI: 10.21292/2075-1230-2022-100-1-41-48

Year: 2022

Biobank as a key component of supporting research in phthisiology and infectious diseases

DOI: 10.15829/1728-8800-2021-3084

Year: 2022

Renaissance of 4-(5-nitrofuran-2-yl)-5-arylamino substituted pyrimidines: microwave-assisted synthesis and antitubercular activity

DOI: 10.1016/J.MENCOM.2021.03.021

Year: 2021

Antimycobacterial signaling pathways are differentially regulated in alveolar macrophages of tuberculosis patients

DOI: 10.1183/13993003.congress-2021.pa2471

Year: 2021

Phenotypic resistance of M. tuberculosis to bedaquilin (BDQ) and linezolid (LZD)

DOI: 10.1183/13993003.congress-2021.pa1041

Year: 2021

Practical approach to detection and surveillance of emerging highly resistant Mycobacterium tuberculosis Beijing 1071-32-cluster

DOI: 10.1038/s41598-021-00890-7

Year: 2021

Mycobacterium tuberculosis Load in Host Cells and the Antibacterial Activity of Alveolar Macrophages Are Linked and Differentially Regulated in Various Lung Lesions of Patients with Pulmonary Tuberculosis

DOI: 10.3390/ijms22073452

Year: 2021

Prevalence of the epidemic variants of the Mycobacterium tuberculosis Beijing genotype across Russian regions

DOI: 10.1183/13993003.congress-2021.pa1723

Year: 2021

Development of technology for longterm storage of Mycobacterium tuberculosis cultures

DOI: 10.36488/cmac.2021.4.404-408

Year: 2021

What is Genomics?

What are the challenges in controlling Plasmodium falciparum malaria?

How Do Antibiotics Work?

What Can Individuals Do to Help?

What Are the Main Treatment Options?

What Are the Common Symptoms of Infectious Diseases?

Can Artemisinin Be Used for Other Infectious Diseases?

What are the Treatment Options for Cervical Cancer?

What are Sporozoites?

How Can Chlamydia Be Prevented?

Partnered Content Networks

Relevant Topics